Lundbeck
HLUN-B.CO
#2596
Rank
NZ$11.46 B
Marketcap
NZ$12.08
Share price
0.63%
Change (1 day)
16.53%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): NZ$1.03

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.06. In 2024 the company made an earnings per share (EPS) of NZ$0.77 an increase over its 2023 EPS that were of NZ$0.59.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.0334.92%
2024NZ$0.7729.29%
2023NZ$0.5923.09%
2022NZ$0.4837.26%
2021NZ$0.35-84.61%
2020NZ$2.28-24.61%
2019NZ$3.02-42.06%
2018NZ$5.2140.7%
2017NZ$3.71146.26%
2016NZ$1.50-120.48%
2015NZ-$7.353231.32%
2014NZ-$0.22-115.78%
2013NZ$1.40-23.36%
2012NZ$1.82-48.01%
2011NZ$3.51-9.68%
2010NZ$3.8813.72%
2009NZ$3.4124.32%
2008NZ$2.75-6.05%
2007NZ$2.9281.77%
2006NZ$1.61-16.76%
2005NZ$1.93-17.58%
2004NZ$2.34